Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organisms Patent now opens up ...

With a 10.66% CAGR, Medical Biotechnology Emerges as the Cornerstone of Precision Medicine and Biopharmaceutical Innovation.Austin, United States, March 26, 2026 (GLOBE NEWSWIRE) -- Red Biotechnology ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus ...

As reported by Reuters, the Patent Trial and Appeal Board found that Broad scientists had conceived the practical eukaryotic ...

Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needsAI-driven ...

From a financial perspective, Prime Medicine appears well-positioned for its near-term goals. The company's cash reserves are sufficient to fund operations into 2027, a necessary buffer given its ...

Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...

In the past year or two, I’ve started to notice that Hawaii has had a much bigger impact beyond our shores than one might expect from a small state with less than one-half of 1% of the U.S.

A parliamentary panel has recommended setting up a regulatory body to fix seed prices in India, stressed the urgent need for ...

Q4 2025 earnings call: commercialization shift, new recombinant product launches, partners, 2026 revenue outlook & cash runway.

What if gene editing could be designed as precisely as a race car tuned to a specific track?With new funding from Genome Canada and Ontario Genomics ...